Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Net Cash Flow (2016 - 2026)

Dexcom has reported Net Cash Flow over the past 17 years, most recently at $202.1 million for Q1 2026.

  • Quarterly Net Cash Flow fell 31.84% to $202.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $195.9 million through Mar 2026, up 256.18% year-over-year, with the annual reading at $290.3 million for FY2025, 515.04% up from the prior year.
  • Net Cash Flow was $202.1 million for Q1 2026 at Dexcom, up from -$921.6 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $677.7 million in Q3 2025 and troughed at -$921.6 million in Q4 2025.
  • The 5-year median for Net Cash Flow is -$3.9 million (2024), against an average of $3.4 million.
  • Year-over-year, Net Cash Flow skyrocketed 2331.78% in 2023 and then crashed 23530.77% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$62.6 million in 2022, then plummeted by 33.23% to -$83.4 million in 2023, then soared by 95.32% to -$3.9 million in 2024, then crashed by 23530.77% to -$921.6 million in 2025, then surged by 121.93% to $202.1 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Net Cash Flow are $202.1 million (Q1 2026), -$921.6 million (Q4 2025), and $677.7 million (Q3 2025).